Business Context and Reporting Period
This Form 8-K was filed by OneMedNet Corporation (ONMD) on March 14, 2025, reporting events occurring on March 12, 2025. The Company is incorporated in Delaware and its securities trade on The Nasdaq Stock Market LLC. The filing addresses a notice of deficiency regarding continued listing standards.
Key Financial Metrics and Listing Deficiencies
The filing identifies specific financial thresholds the Company failed to meet, triggering the Nasdaq notice:
- Market Value of Listed Securities (MVLS): Below the required minimum of $35 million for 31 consecutive business days prior to March 12, 2025.
- Stockholders' Equity: Below the required minimum of $2.5 million (Rule 5550(b)(1)).
- Net Income: Below the required minimum of $500,000 from continuing operations (Rule 5550(b)(3)).
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity beyond the stated non-compliance with the minimum thresholds.
Material Changes and Compliance Timeline
The material change is the receipt of a formal deficiency notice from Nasdaq. The Company has been granted a 180-calendar-day compliance period, ending on September 8, 2025. To regain compliance with the MVLS requirement, the Company must close at or above $35 million for a minimum of ten consecutive business days during this period. Failure to comply by the deadline may result in delisting, subject to appeal.
Outlook, Risks, and Management Commentary
Management states it intends to actively monitor the MVLS and evaluate available options to resolve the deficiency. However, the Company explicitly notes there can be no assurance that it will be able to regain or maintain compliance with Nasdaq listing standards. The notice is currently a notification of deficiency and has no immediate effect on the trading of the Company's securities.
Investor Verification Checklist
- Verify the current Market Value of Listed Securities (MVLS) to assess proximity to the $35 million threshold.
- Review the most recent audited financial statements to confirm the exact figures for stockholders' equity and net income.
- Monitor for any subsequent filings regarding capital raises, reverse stock splits, or other corporate actions intended to restore compliance.
- Check for any updates on the Company's ability to meet the September 8, 2025, compliance deadline.